Company attributes
Industry
B2X
Founder
AngelList URL
Pitchbook URL
Legal Name
Transposagen Biopharmaceuticals, Inc.
Legal classification
Number of Employees (Ranges)
11 – 50
Full Address
145 GRAHAM AVENUE, SUITE A217, LEXINGTON, KY, 40506
CIK Number
Founded Date
2005
0Total Funding Amount (USD)
6,680,000
Latest Funding Round Date
February 2015
Latest Funding Type
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Wikidata ID
Transposagen was founded in 2003 to commercialize early gene editing technology. Since then, Transposagen has merged with Hera BioLabs and has increased its scientific offerings to include a suite of gene editing technologies and services that address the research needs of both academic and drug discovery investigators.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
